Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FX7Y9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $2,082.90 delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of Nexplanon 68 mg implants, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The contract was not issued under a small business set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as the prime contractor with no identified subcontractors on this delivery order.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its IDC to deliver an extensive portfolio of pharmaceutical products—including prescription medications, biologics, and medical consumables—to military and federal healthcare facilities nationwide. The SPE2DB program enables the DLA to efficiently procure specialized medical products such as Nexplanon contraceptive implants to support the healthcare needs of Department of Defense facilities. This delivery order exemplifies the company's ongoing role in supplying contraceptive and pharmaceutical products to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FX7Y9?
SPE2DB25FX7Y9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FX7Y9 worth?
The government has obligated $2,083 on SPE2DB25FX7Y9.
Is contract SPE2DB25FX7Y9 an order under another contract?
Yes. SPE2DB25FX7Y9 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Y9 competed?
The extent of competition for SPE2DB25FX7Y9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award